Royal Fund Management »

Viking Therapeutics shares owned by Royal Fund Management

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Royal Fund Management from 13F filings

Historical chart of Royal Fund Management investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Royal Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Royal Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $807k 13k 63.31
2024-06-30 $673k 13k 53.01

More positions owned by Royal Fund Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Vanguard World Inf Tech Etf (VGT)
Select Sector Spdr Tr Financial (XLF)
Spdr Ser Tr S&p Biotech (XBI)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&P SML 600 GWT (IJT)
Uber Technologies Call Option (UBER)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Royal Fund Management

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Perpetual
Alliancebernstein
Goldman Sachs Group
Braidwell
Jane Street

View all funds holding Viking Therapeutics